By Iain Gilbert
Date: Monday 02 Feb 2026
(Sharecast News) - Analysts at Canaccord Genuity lifted enterprise software firm Sage from 'hold' to 'buy' on Monday, arguing that a recent sell-off has created an attractive entry point for investors.
| Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc | 03-Feb-2026 | 07:48 | RNS |
| Transaction in Own Shares | 03-Feb-2026 | 07:00 | RNS |
| Transaction in Own Shares | 03-Feb-2026 | 07:00 | RNS |
| Transaction in Own Shares | 03-Feb-2026 | 07:00 | RNS |
| Transaction in Own Shares | 03-Feb-2026 | 07:00 | RNS |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor :Ricardo | 31-Oct-2014 | Telegraph |
| Questor:CSR | 17-Oct-2014 | Telegraph |
| Questor:BAE Systems | 03-Sep-2014 | Telegraph |
| Questor :Sage Group | 09-May-2014 | Telegraph |
| Price | 8,739.96 |
| Change Today | 0.00 |
| % Change | 0.00 % |
| 02-Feb-26 Close | 8,739.96 |
You are here: research